GOSSAMER BIO INC's ticker is GOSS and the CUSIP is 38341P102. A total of 135 filers reported holding GOSSAMER BIO INC in Q4 2021. The put-call ratio across all filers is 1.25 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2022 | $6,014,162 | +118.8% | 2,771,503 | +1107.9% | 0.05% | +72.4% |
| Q3 2022 | $2,749,000 | +125.3% | 229,445 | +57.4% | 0.03% | +163.6% |
| Q2 2022 | $1,220,000 | -26.2% | 145,746 | -23.5% | 0.01% | +10.0% |
| Q1 2022 | $1,653,000 | -20.5% | 190,473 | +3.6% | 0.01% | -9.1% |
| Q4 2021 | $2,079,000 | +112.8% | 183,844 | +136.4% | 0.01% | +57.1% |
| Q3 2021 | $977,000 | +6.7% | 77,760 | -31.1% | 0.01% | +16.7% |
| Q2 2021 | $916,000 | -43.0% | 112,850 | -35.0% | 0.01% | -45.5% |
| Q1 2021 | $1,606,000 | +563.6% | 173,628 | +594.1% | 0.01% | +450.0% |
| Q4 2020 | $242,000 | -59.3% | 25,016 | -47.7% | 0.00% | -71.4% |
| Q3 2020 | $594,000 | +172.5% | 47,833 | +184.9% | 0.01% | +133.3% |
| Q2 2020 | $218,000 | -67.4% | 16,791 | -60.7% | 0.00% | -70.0% |
| Q4 2019 | $668,000 | – | 42,710 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Omega Fund Management, LLC | 3,164,835 | $27,471,000 | 5.62% |
| Kynam Capital Management, LP | 1,832,704 | $15,908,000 | 5.16% |
| Octagon Capital Advisors LP | 2,563,138 | $22,248,000 | 4.81% |
| Ally Bridge Group (NY) LLC | 450,000 | $3,906,000 | 2.90% |
| HHLR ADVISORS, LTD. | 7,420,974 | $64,414,000 | 1.34% |
| Palo Alto Investors LP | 1,756,757 | $15,249,000 | 1.18% |
| Boxer Capital, LLC | 2,462,358 | $21,373,000 | 1.10% |
| Ikarian Capital, LLC | 775,315 | $6,730,000 | 0.88% |
| Artal Group S.A. | 2,358,968 | $20,476,000 | 0.86% |
| Birchview Capital, LP | 129,088 | $1,120,000 | 0.81% |